• Mashup Score: 11

    Background and Objectives Infections play a key role in the development of Guillain-Barré syndrome (GBS) and have been associated with specific clinical features and disease severity. The clinical variation of GBS across geographical regions has been suggested to be related to differences in the distribution of preceding infections, but this has not been studied on a large scale. Methods We…

    Tweet Tweets with this article
    • An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort https://t.co/REqt21KkBw #Neurology #NeuroTwitter #GuillainBarre https://t.co/Iolazzef0j

  • Mashup Score: 11

    Developing cultural humility in immunology and STEMM mentoringCultural humility allows a better understanding and appreciation of others, as well as fostering positive interactions with different kinds of individuals. Here, we discuss the difficulties faced by persons excluded because of their ethnicity or race (PEERs) in immunology and science, technology, engineering, mathematics, and medicine…

    Tweet Tweets with this article
    • Check out @TrendsImmuno April issue! #NAD in #COVID19, #Tfh survival, #GuillainBarre & #mimicry, #BCG #vaccination & #crossprotection, #odorant #receptors, old #macrophages, #LongCovid, #SARSCoV2 #vaccination, #TLS, #magnesium for #Tcells, #ICOS & more! https://t.co/uMv3atEBoQ https://t.co/qoy6EZF62Q

  • Mashup Score: 5

    Based on the Vaccine Adverse Event Reporting System, this article reports on the prevalence of presumptive Guillain-Barré syndrome among recipients of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine.

    Tweet Tweets with this article
    • Study suggests a potential small but statistically significant safety concern for #GuillainBarré syndrome following receipt of the @JanssenUS #COVID19 vaccine; findings considered preliminary pending analysis of medical records to establish a definitive Dx https://t.co/yZjJVkp6BA

  • Mashup Score: 5

    The ACIP discussed slightly higher rates of the rare side effect of Guillain-Barré syndrome after the J&J vaccine, and presented reaffirming evidence of the vaccine’s effectiveness against variants.

    Tweet Tweets with this article
    • Despite recent reports of #GuillainBarré Syndrome after the Johnson and Johnson vaccine, CDC advisors agree benefits still outweigh risks.https://t.co/QaXiZIL6qX https://t.co/F3f9Vp72uQ